Cardiovascular Therapeutics

SJR Rank #6,229H-index: 62SJR: 0.857Best quartile: Q2Open AccessAPC: US$2,160Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

John Wiley and Sons Inc

Country

China

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Cardiology and Cardiovascular MedicineQ2
  • Medicine (miscellaneous)Q2
  • PharmacologyQ2
  • Pharmacology (medical)Q2

Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Atrial Fibrillation Management and OutcomesLipoproteins and Cardiovascular HealthHeart Failure Treatment and ManagementCardiovascular Function and Risk FactorsAntiplatelet Therapy and Cardiovascular DiseasesCardiac Fibrosis and RemodelingCoronary Interventions and DiagnosticsCardiac electrophysiology and arrhythmiasBlood Pressure and Hypertension StudiesAcute Myocardial Infarction Research

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs03570105140

Documents per Year

20222025020406080

Detailed Information

ISSN

1755-5914, 1755-5922

SJR Best Quartile

Q2

Region

Asiatic Region

Citations per Document (2 years)

2.83

References per Document

42.16

Coverage

2008-2026

Scope

Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) is a peer-reviewed, Open Access journal that publishes original research and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of new cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies, and pharmacoepidemiology are also encouraged. Subject areas include (but are by no means limited to): Acute coronary syndrome Arrhythmias Atherosclerosis Basic cardiac electrophysiology Cardiac catheterization Cardiac remodeling Coagulation and thrombosis Diabetic cardiovascular disease Heart failure (systolic HF, HFrEF, diastolic HF, HFpEF) Hyperlipidemia Hypertension Ischemic heart disease Vascular biology Ventricular assist devices Molecular cardio-biology Myocardial regeneration Lipoprotein metabolism Radial artery access Percutaneous coronary intervention Transcatheter aortic and mitral valve replacement.

Metrics from SCImago Journal Rank 2025. View on SCImago